or Try an Advanced Search...

    Technical Analysis for LUCD - Lucid Diagnostics Inc.

    Grade Last Price % Change Price Change
    D 0.79 -3.78% -0.03
    LUCD closed down 3.78 percent on Monday, July 1, 2024, on 72 percent of normal volume.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Up
    Historical LUCD trend table...
    Date Alert Name Type % Chg
    20 DMA Support Bullish 0.00%
    Fell Below 50 DMA Bearish -3.78%
    New Uptrend Bullish -3.78%
    Outside Day Range Expansion -3.78%
    Wide Bands Range Expansion -3.78%
    50 DMA Support Bullish -9.21%
    Inside Day Range Contraction -9.21%
    Wide Bands Range Expansion -9.21%
    Up 3 Days in a Row Strength -9.21%
    Up 4 Days in a Row Strength -9.21%
    Older End-of-Day Signals for LUCD ...

       Recent Intraday Alerts

    Alert Time
    50 DMA Support 3 days ago
    60 Minute Opening Range Breakdown 3 days ago
    Outside Day 3 days ago
    Down 5% 3 days ago
    Down 3% 3 days ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    LUCD Chart by TradingView
    Basic chart:

    Profile

    Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company. It focuses on patients with gastroesophageal reflux disease, also known as chronic heartburn, acid reflux or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma. The company's lead products include EsoGuard, a laboratory developed esophageal DNA test that examines individuals DNA molecules for the presence or absence of cytosine methylation; and EsoCheck, a cell collection device that collects cells of targeted region of the esophagus. Lucid Diagnostics Inc. was incorporated in 2018 and is based in New York, New York. Lucid Diagnostics Inc. is a subsidiary of PAVmed Inc.
    Classification
    Sector: Healthcare
    Industry: Medical Devices
    Keywords: Cancer Gastroenterology Digestive Diseases Esophageal Cancer

    Is LUCD a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 3 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 9 Legacy Sponge-on-a-String Esophageal Cell Collection Device Subject of Class II FDA Recall
    May 7 Lucid Diagnostics Closes Series B / B-1 Preferred Stock Offering and Appoints Healthcare Industry Veteran Dennis Matheis to Board of Directors
    Apr 29 Lucid Diagnostics Partners with the Esophageal Cancer Action Network (ECAN) to Highlight Esophageal Cancer Awareness Month
    Apr 19 3 Penny Stocks That Could Make a Big Comeback by the End of Q2
    Mar 25 Lucid Diagnostics reports preliminary Q4 results
    Mar 25 Lucid Diagnostics Provides Business Update and Preliminary Fourth Quarter and Full Year 2023 Financial Results
    Mar 25 Earnings Scheduled For March 25, 2024
    Mar 22 Earnings Preview: Lucid Diagnostics
    Mar 21 Lucid Diagnostics Announces Positive Data from the First Prospective Clinical Validation Study of EsoGuard® Esophageal Precancer Testing in a Screening Population
    Mar 20 Lucid Diagnostics Announces Multiple Presentations at the Upcoming Digestive Disease Week (DDW) 2024 Conference
    See more LUCD news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 1.721
    52 Week Low 0.6301
    Average Volume 199,850
    200-Day Moving Average 1.17
    50-Day Moving Average 0.84
    20-Day Moving Average 0.78
    10-Day Moving Average 0.78
    Average True Range 0.06
    RSI (14) 46.81
    ADX 25.16
    +DI 25.95
    -DI 16.35
    Chandelier Exit (Long, 3 ATRs) 0.74
    Chandelier Exit (Short, 3 ATRs) 0.87
    Upper Bollinger Bands 0.90
    Lower Bollinger Band 0.66
    Percent B (%b) 0.54
    BandWidth 29.96
    MACD Line -0.01
    MACD Signal Line -0.03
    MACD Histogram 0.0132
    Fundamentals Value
    Market Cap 33.83 Million
    Num Shares 42.9 Million
    EPS -1.41
    Price-to-Earnings (P/E) Ratio -0.56
    Price-to-Sales 37.16
    Price-to-Book 2.16
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.86
    Resistance 3 (R3) 0.87 0.84 0.85
    Resistance 2 (R2) 0.84 0.82 0.84 0.85
    Resistance 1 (R1) 0.82 0.81 0.80 0.81 0.84
    Pivot Point 0.79 0.79 0.79 0.79 0.79
    Support 1 (S1) 0.77 0.77 0.76 0.76 0.74
    Support 2 (S2) 0.74 0.76 0.74 0.73
    Support 3 (S3) 0.72 0.74 0.73
    Support 4 (S4) 0.71